Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for walking ability in peripheral artery disease
ACTRN12618001186246Phase 4Recruiting
- Sponsor
- James Cook University
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in arteriosclerosis obliterans comparing Metformin with Placebo (2 arms). Primary endpoint: Maximum walking distance during six minute walk test. Started Jun 2019; status: recruiting.
02
Drugs
metformin
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on ACTRN12618001186246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001186246.